Eric Easom - 31 Oct 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Issuer symbol
ANTX
Transactions as of
31 Oct 2022
Net transactions value
-$64,625
Form type
4
Filing time
02 Nov 2022, 20:52:11 UTC
Previous filing
28 Oct 2022
Next filing
07 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale $41,363 -2,688 -29% $15.39 6,451 31 Oct 2022 Direct F1
transaction ANTX Common Stock Sale $23,263 -1,544 -24% $15.07 4,907 02 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.